Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculature. Stein CM, Brown N, Vaughan DE, Lang CC, Wood AJ (1998) J Am Coll Cardiol 32: 117-22 Regulation of the synthesis and activity of urokinase plasminogen activator in A549 human lung carcinoma cells by transforming growth factor-beta. Keski-Oja J, Blasi F, Leof EB, Moses HL (1988) J Cell Biol 106: 451-9 Differential effects of nebivolol and metoprolol on insulin sensitivity and plasminogen activator inhibitor in the metabolic syndrome. Ayers K, Byrne LM, DeMatteo A, Brown NJ (2012) Hypertension 59: 893-8 Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-beta. Divergent responses in lung fibroblasts and carcinoma cells. Keski-Oja J, Raghow R, Sawdey M, Loskutoff DJ, Postlethwaite AE, Kang AH, Moses HL (1988) J Biol Chem 263: 3111-5 Alternative splicing yields novel BMAL2 variants: tissue distribution and functional characterization. Schoenhard JA, Eren M, Johnson CH, Vaughan DE (2002) Am J Physiol Cell Physiol 283: C103-14
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.